Fostering Research Synergies between Chemists in Swiss Academia and at Novartis

Authors

  • Arndt Meyer Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel
  • Daniel Baeschlin Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel
  • Cara E. Brocklehurst Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel
  • Myriam Duckely Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel
  • Fabrice Gallou Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel
  • Lucie E. Lovelle Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel
  • Michael Parmentier Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel
  • Thierry Schlama Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel
  • Radka Snajdrova Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel
  • Yves Auberson Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel

DOI:

https://doi.org/10.2533/chimia.2021.936

PMID:

34798915

Keywords:

Drug discovery, Chemical Development, Partnerships, Collaborations, Chemistry

Abstract

We present a short overview of the way Novartis chemists interact and collaborate with the academic chemistry community in Switzerland. This article exemplifies a number of collaborations, and illustrates opportunities to foster research synergies between academic and industrial researchers. It also describes established programs available to academic groups, providing them access to Novartis resources and expertise.

Downloads

Published

2021-11-11

How to Cite

[1]
A. Meyer, D. Baeschlin, C. E. Brocklehurst, M. Duckely, F. Gallou, L. E. Lovelle, M. Parmentier, T. Schlama, R. Snajdrova, Y. Auberson, Chimia 2021, 75, 936, DOI: 10.2533/chimia.2021.936.